CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow

Cancer Immunology, Immunotherapy

Volumn 57, Issue 4, 2008, Pages 541-548

  Airoldi, Irma ^a   Cocco, Claudia ^a   Morandi, Fabio ^a   Prigione, Ignazia ^a   Pistoia, Vito ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Chemokine receptors; Chemokines; Neuroblastoma

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR5;

ARTICLE; BONE MARROW; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MAJOR CLINICAL STUDY; METASTASIS; NEUROBLASTOMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL;

BONE MARROW; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT; NEOPLASM METASTASIS; NEUROBLASTOMA; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR5; RECEPTORS, SCAVENGER; RECEPTORS, VIRUS;

EID: 38649117620     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0392-2     Document Type: Article

References (27)

1. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216
2. Cotterill SJ, Pearson AD, Pritchard J, Kohler JA, Foot AB (2001) Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey". Med Pediatr Oncol 36:235-238
3. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24:1030-1041
4. Katschke KJ Jr, Rottman JB, Ruth JH et al (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 44:1022-1032
5. Qin S, Rottman JB, Myers P et al (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-754
6. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
7. Schioppa T, Uranchimeg B, Saccani A et al (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198:1391-1402
8. Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56
9. Murphy PM (2001) Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345:833-835
10. Pistoia V, Corcione A, Dallegri F, Ottonello L (2006) Lymphoproliferative disorders and chemokines. Curr Drug Targets 7:81-90
11. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
12. Airoldi I, Raffaghello L, Piovan E, Cocco C, Carlini B, Amadori A, Corrias MV, Pistoia V (2006) CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications. Clin Cancer Res 12:77-82
13. Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP, Ben-Baruch A (2001) A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167:4747-4757
14. Metelitsa LS, Wu HW, Wang H et al (2004) Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 199:1213-1221
15. Ferrer FA, Pantschenko AG, Miller LJ, Anderson K, Grunnet M, McKenna PH, Kreutzer D (2000) Angiogenesis and neuroblastomas: interleukin-8 and interleukin-8 receptor expression in human neuroblastoma. J Urol 164:1016-1020
16. Goldberg-Bittman L, Sagi-Assif O, Meshel T, Nevo I, Levy-Nissenbaum O, Yron I, Witz IP, Ben-Baruch A (2005) Cellular characteristics of neuroblastoma cells: regulation by the ELR-CXC chemokine CXCL10 and expression of a CXCR3-like receptor. Cytokine 29:105-117
17. Brodeur GM, Pritchard J, Berthold F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477
18. Puppo M, Pastorino S, Melillo G, Pezzolo A, Varesio L, Bosco MC (2004) Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation. Clin Cancer Res 10:8704-8719
19. Flynn G, Maru S, Loughlin J, Romero IA, Male D (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136:84-93
20. Meijer J, Zeelenberg IS, Sipos B, Roos E (2006) The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer Res 66:9576-9582
21. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI (2006) Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 210:363-373
22. Seidl H, Richtig E, Tilz H et al (2007) Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Hum Pathol 38(5):768-780
23. Russell HV, Hicks J, Okcu MF, Nuchtern JG (2004) CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg 39:1506-1511
24. Smith JR, Braziel RM, Paoletti S, Lipp M, Uguccioni M, Rosenbaum JT (2003) Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 101:815-821
25. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565-568
26. Lisignoli G, Cristino S, Toneguzzi S, Grassi F, Piacentini A, Cavallo C, Facchini A, Mariani E (2004) IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. Exp Gerontol 39:659-665
27. Haskell CA, Cleary MD, Charo IF (1999) Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274:10053-10058